<!doctype html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Adrenal Disorders - Clinical Study Note</title>
    <link rel="icon" type="image/png" sizes="48x48" href="/icons/favicon-48.png?v=20260227-favicon1" />
    <link rel="icon" type="image/png" sizes="32x32" href="/icons/favicon-32.png?v=20260227-favicon1" />
    <link rel="icon" type="image/png" sizes="16x16" href="/icons/favicon-16.png?v=20260227-favicon1" />
    <link rel="apple-touch-icon" sizes="180x180" href="/icons/favicon-180.png?v=20260227-favicon1" />
    <style>
      :root {
        --bg: #f8fbff;
        --surface: #ffffff;
        --ink: #132841;
        --muted: #556c84;
        --line: #d7e4f0;
        --brand: #6a3f0f;
        --brand-soft: #fff6ea;
        --teal-soft: #eefaf6;
        --warn-soft: #fff7e8;
        --danger-soft: #fff0f0;
      }

      * {
        box-sizing: border-box;
      }

      body {
        margin: 0;
        font-family: "Segoe UI", Tahoma, Arial, sans-serif;
        color: var(--ink);
        background:
          radial-gradient(circle at 84% 8%, #ffe9c9 0%, transparent 31%),
          radial-gradient(circle at 10% 20%, #e9f4ff 0%, transparent 24%),
          var(--bg);
      }

      .wrap {
        width: min(1240px, 94vw);
        margin: 22px auto 34px;
        display: grid;
        grid-template-columns: 290px 1fr;
        gap: 16px;
      }

      .panel {
        background: var(--surface);
        border: 1px solid var(--line);
        border-radius: 16px;
        box-shadow: 0 10px 24px rgba(13, 34, 62, 0.06);
      }

      .toc {
        position: sticky;
        top: 16px;
        max-height: calc(100dvh - 32px);
        overflow: auto;
        padding: 14px;
      }

      .toc h2 {
        margin: 0 0 10px;
        color: var(--brand);
        font-size: 1rem;
      }

      .toc a {
        display: block;
        text-decoration: none;
        color: #36506c;
        border-radius: 8px;
        padding: 7px 9px;
        font-size: 13px;
      }

      .toc a:hover {
        background: #fff8ee;
        color: #6a3f0f;
      }

      .content {
        padding: 0 0 18px;
      }

      .hero {
        padding: 20px;
        border-bottom: 1px solid var(--line);
        background: linear-gradient(160deg, #ffffff 0%, #fff8ef 56%, #eef7ff 100%);
      }

      .eyebrow {
        display: inline-flex;
        align-items: center;
        min-height: 28px;
        padding: 5px 12px;
        border-radius: 999px;
        background: var(--brand-soft);
        color: #6a3f0f;
        font-size: 12px;
        font-weight: 700;
        margin-bottom: 10px;
      }

      h1 {
        margin: 0;
        color: #58350d;
        font-size: clamp(1.42rem, 2.4vw, 2.04rem);
      }

      .subtitle {
        margin: 8px 0 0;
        color: var(--muted);
        line-height: 1.55;
      }

      .hero-layout {
        margin-top: 14px;
        display: grid;
        grid-template-columns: 1.35fr 0.95fr;
        gap: 12px;
      }

      .hero-grid {
        display: grid;
        grid-template-columns: repeat(4, minmax(0, 1fr));
        gap: 10px;
      }

      .metric {
        border: 1px solid #f1e1c9;
        border-radius: 12px;
        background: #fff;
        padding: 10px;
      }

      .metric .k {
        font-size: 11px;
        color: #7d6a57;
        margin-bottom: 6px;
        text-transform: uppercase;
        letter-spacing: 0.3px;
      }

      .metric .v {
        font-size: 14px;
        color: #58350d;
        font-weight: 700;
      }

      .hero-visual {
        border: 1px solid #f0e0c8;
        border-radius: 14px;
        background: #fff;
        padding: 10px;
        display: grid;
        gap: 8px;
      }

      .hero-visual h3 {
        margin: 0;
        font-size: 0.95rem;
        color: #58350d;
      }

      .hero-visual p {
        margin: 0;
        font-size: 0.84rem;
        color: #5d758c;
      }

      .hero-visual svg {
        width: 100%;
        height: auto;
        display: block;
      }

      .section {
        padding: 16px 20px;
        border-bottom: 1px solid #edf3fb;
      }

      .section:last-child {
        border-bottom: none;
      }

      .section h2 {
        margin: 0 0 10px;
        color: #58350d;
        font-size: 1.16rem;
      }

      .section p {
        margin: 0;
        color: #314860;
        line-height: 1.56;
      }

      .stack {
        margin-top: 10px;
        display: grid;
        gap: 10px;
      }

      .grid-2 {
        display: grid;
        grid-template-columns: repeat(2, minmax(0, 1fr));
        gap: 10px;
      }

      .grid-3 {
        display: grid;
        grid-template-columns: repeat(3, minmax(0, 1fr));
        gap: 10px;
      }

      .box {
        border: 1px solid var(--line);
        border-radius: 12px;
        padding: 11px 12px;
        background: #fff;
      }

      .box h3 {
        margin: 0 0 7px;
        font-size: 0.97rem;
        color: #1f4061;
      }

      .box p {
        margin: 0;
      }

      .box ul {
        margin: 0 0 0 17px;
        padding: 0;
      }

      .box li {
        margin: 4px 0;
        color: #304860;
      }

      .table {
        margin-top: 8px;
        width: 100%;
        border-collapse: collapse;
        border-radius: 12px;
        border: 1px solid var(--line);
        overflow: hidden;
      }

      .table th,
      .table td {
        padding: 10px;
        text-align: left;
        font-size: 14px;
        border-bottom: 1px solid #e8eff8;
        vertical-align: top;
      }

      .table th {
        background: #fff8ef;
        color: #58350d;
      }

      .table tr:last-child td {
        border-bottom: none;
      }

      .chips {
        margin-top: 8px;
        display: flex;
        gap: 8px;
        flex-wrap: wrap;
      }

      .chip {
        display: inline-flex;
        align-items: center;
        min-height: 30px;
        padding: 4px 10px;
        border-radius: 999px;
        border: 1px solid #d8e4f2;
        background: #f8fbff;
        color: #254764;
        font-size: 13px;
        font-weight: 600;
      }

      .callout {
        margin-top: 10px;
        border-left: 4px solid #0f766e;
        border-radius: 10px;
        background: var(--teal-soft);
        color: #175358;
        padding: 10px 12px;
      }

      .callout.warn {
        border-left-color: #b66a00;
        background: var(--warn-soft);
        color: #7c5b1d;
      }

      .callout.alert {
        border-left-color: #b91c1c;
        background: var(--danger-soft);
        color: #6d2222;
      }

      .flow {
        margin-top: 10px;
        display: grid;
        gap: 9px;
      }

      .step {
        border: 1px solid #d5e3f4;
        border-radius: 12px;
        padding: 10px 11px;
        background: #f9fcff;
      }

      .step strong {
        color: #58350d;
      }

      .arrow {
        width: 30px;
        height: 30px;
        margin: 0 auto;
        border-radius: 999px;
        border: 1px solid #c9d8ec;
        background: #f6fbff;
        color: #456887;
        font-weight: 900;
        display: grid;
        place-items: center;
        line-height: 1;
      }

      .diagram-card {
        margin-top: 10px;
        border: 1px solid #d8e4f2;
        border-radius: 12px;
        background: #fbfdff;
        padding: 11px;
      }

      .diagram-title {
        margin: 0 0 8px;
        font-size: 0.9rem;
        color: #1d3f62;
        font-weight: 700;
      }

      .refs a {
        color: #145aa9;
        text-decoration: none;
        word-break: break-word;
      }

      .refs a:hover {
        text-decoration: underline;
      }

      @media (max-width: 1040px) {
        .wrap {
          grid-template-columns: 1fr;
        }

        .toc {
          position: static;
          max-height: none;
        }

        .hero-layout {
          grid-template-columns: 1fr;
        }

        .hero-grid {
          grid-template-columns: repeat(2, minmax(0, 1fr));
        }
      }

      @media (max-width: 760px) {
        .grid-2,
        .grid-3,
        .hero-grid {
          grid-template-columns: 1fr;
        }
      }
    </style>
  </head>
  <body>
    <div class="wrap">
      <aside class="panel toc">
        <h2>On This Page</h2>
        <a href="#adrenal-physiology">1. Adrenal Physiology</a>
        <a href="#cushing-syndrome">2. Cushing Syndrome</a>
        <a href="#addison-disease">3. Addison Disease</a>
        <a href="#adrenal-crisis">4. Adrenal Crisis</a>
        <a href="#secondary-adrenal-insufficiency">5. Secondary Adrenal Insufficiency</a>
        <a href="#primary-hyperaldosteronism">6. Primary Hyperaldosteronism</a>
        <a href="#management-recap-drill">Recap Drill</a>
        <a href="#exam-traps">7. Common Exam Traps</a>
        <a href="#quick-revision">8. Quick Revision Summary</a>
      </aside>

      <article class="panel content">
        <header class="hero">
          <span class="eyebrow">Endocrinology</span>
          <h1>Adrenal Disorders</h1>
          <p class="subtitle">
            Clinical overview and exam mastery guide for cortisol excess/deficiency,
            adrenal crisis emergency care, and hyperaldosteronism treatment.
          </p>

          <div class="hero-layout">
            <div class="hero-grid">
              <div class="metric">
                <div class="k">Cushing</div>
                <div class="v">Excess cortisol</div>
              </div>
              <div class="metric">
                <div class="k">Addison</div>
                <div class="v">Low cortisol plus low aldosterone</div>
              </div>
              <div class="metric">
                <div class="k">Adrenal Crisis</div>
                <div class="v">Immediate IV hydrocortisone</div>
              </div>
              <div class="metric">
                <div class="k">Conn Syndrome</div>
                <div class="v">Aldosterone excess</div>
              </div>
            </div>

            <div class="hero-visual">
              <h3>Adrenal Axis Snapshot</h3>
              <svg viewBox="0 0 500 220" role="img" aria-label="Adrenal disorders overview">
                <rect x="0" y="0" width="500" height="220" rx="14" fill="#fbfdff" />
                <rect x="20" y="30" width="146" height="72" rx="10" fill="#fff8ef" stroke="#f1e1c9" />
                <text x="93" y="54" text-anchor="middle" font-size="13" fill="#58350d" font-weight="700">Cortex</text>
                <text x="93" y="72" text-anchor="middle" font-size="12" fill="#7d6a57">cortisol</text>
                <text x="93" y="88" text-anchor="middle" font-size="12" fill="#7d6a57">aldosterone</text>

                <rect x="176" y="30" width="146" height="72" rx="10" fill="#eef7ff" stroke="#d8e6f6" />
                <text x="249" y="54" text-anchor="middle" font-size="13" fill="#1f4467" font-weight="700">Medulla</text>
                <text x="249" y="72" text-anchor="middle" font-size="12" fill="#5f7488">epinephrine</text>
                <text x="249" y="88" text-anchor="middle" font-size="12" fill="#5f7488">norepinephrine</text>

                <rect x="332" y="30" width="146" height="72" rx="10" fill="#eefaf7" stroke="#d4ece4" />
                <text x="405" y="54" text-anchor="middle" font-size="13" fill="#1c564f" font-weight="700">Exam focus</text>
                <text x="405" y="72" text-anchor="middle" font-size="12" fill="#5b7a74">cortisol and</text>
                <text x="405" y="88" text-anchor="middle" font-size="12" fill="#5b7a74">aldosterone disorders</text>

                <rect x="20" y="128" width="458" height="68" rx="10" fill="#ffffff" stroke="#d8e4f2" />
                <text x="249" y="154" text-anchor="middle" font-size="13" fill="#2a4963" font-weight="700">
                  Clinical split: excess, deficiency, and emergency decompensation
                </text>
                <text x="249" y="172" text-anchor="middle" font-size="12" fill="#45637e">
                  Replace deficiency, block excess synthesis/effect, and treat crises immediately
                </text>
              </svg>
              <p>Endocrine emergencies require treatment before full diagnostic completion.</p>
            </div>
          </div>
        </header>

        <section class="section" id="adrenal-physiology">
          <h2>1. Adrenal Physiology (Foundation First)</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Cortex</h3>
              <ul>
                <li>Cortisol (glucocorticoid)</li>
                <li>Aldosterone (mineralocorticoid)</li>
                <li>Androgens</li>
              </ul>
            </div>
            <div class="box">
              <h3>Medulla</h3>
              <ul>
                <li>Epinephrine</li>
                <li>Norepinephrine</li>
              </ul>
            </div>
          </div>
          <div class="callout">Most exam questions focus on cortisol and aldosterone disorders.</div>
        </section>

        <section class="section" id="cushing-syndrome">
          <h2>2. Cushing Syndrome (Excess Cortisol)</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Causes</h3>
              <ul>
                <li>Exogenous steroid exposure (most common overall)</li>
                <li>Pituitary adenoma (Cushing disease)</li>
                <li>Adrenal tumor</li>
                <li>Ectopic ACTH production</li>
              </ul>
            </div>
            <div class="box">
              <h3>Clinical Features</h3>
              <ul>
                <li>Central obesity, moon facies, buffalo hump</li>
                <li>Purple striae, hypertension, hyperglycemia</li>
                <li>Osteoporosis and proximal muscle weakness</li>
              </ul>
            </div>
          </div>

          <div class="callout">
            First-line strategy is treating the source (often surgery for a resectable tumor).
          </div>

          <table class="table">
            <thead>
              <tr>
                <th>Drug</th>
                <th>MOA</th>
                <th>Major Side Effects</th>
                <th>Contraindications / Notes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>Ketoconazole</td>
                <td>Inhibits adrenal steroidogenic enzymes and lowers cortisol synthesis</td>
                <td>Hepatotoxicity, GI upset</td>
                <td>Contraindicated in significant liver disease</td>
              </tr>
              <tr>
                <td>Metyrapone</td>
                <td>11-beta-hydroxylase inhibition decreases cortisol production</td>
                <td>Hypertension, hypokalemia</td>
                <td>Mineralocorticoid precursor accumulation can worsen BP/electrolytes</td>
              </tr>
              <tr>
                <td>Mifepristone</td>
                <td>Glucocorticoid receptor antagonist; blocks cortisol effect, not level</td>
                <td>Hypokalemia, endometrial thickening</td>
                <td>Useful in Cushing syndrome with hyperglycemia</td>
              </tr>
            </tbody>
          </table>
        </section>

        <section class="section" id="addison-disease">
          <h2>3. Addison Disease (Primary Adrenal Insufficiency)</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Etiology and Features</h3>
              <ul>
                <li>Adrenal destruction (autoimmune, TB, hemorrhage)</li>
                <li>Fatigue, weight loss, hypotension</li>
                <li>Hyperpigmentation, hyponatremia, hyperkalemia</li>
              </ul>
            </div>
            <div class="box">
              <h3>Replacement Therapy</h3>
              <ul>
                <li>Hydrocortisone for glucocorticoid replacement</li>
                <li>Fludrocortisone for mineralocorticoid replacement</li>
              </ul>
            </div>
          </div>

          <table class="table">
            <thead>
              <tr>
                <th>Drug</th>
                <th>MOA</th>
                <th>Major Side Effects</th>
                <th>Notes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>Hydrocortisone</td>
                <td>Replaces cortisol activity</td>
                <td>Weight gain, hyperglycemia, long-term bone loss</td>
                <td>Foundation of adrenal insufficiency treatment</td>
              </tr>
              <tr>
                <td>Fludrocortisone</td>
                <td>Mineralocorticoid receptor agonist replacing aldosterone effect</td>
                <td>Hypertension, hypokalemia, edema</td>
                <td>Required in primary adrenal insufficiency</td>
              </tr>
            </tbody>
          </table>
        </section>

        <section class="section" id="adrenal-crisis">
          <h2>4. Adrenal Crisis (Emergency)</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Triggers and Features</h3>
              <ul>
                <li>Triggers: infection, surgery, abrupt steroid withdrawal</li>
                <li>Severe hypotension/shock, hypoglycemia, hyponatremia</li>
              </ul>
            </div>
            <div class="box">
              <h3>Immediate Management</h3>
              <ul>
                <li>1. IV hydrocortisone immediately</li>
                <li>2. IV fluids</li>
                <li>3. Electrolyte correction</li>
              </ul>
            </div>
          </div>
          <div class="callout alert">Do not delay treatment while waiting for confirmatory laboratory results.</div>
        </section>

        <section class="section" id="secondary-adrenal-insufficiency">
          <h2>5. Secondary Adrenal Insufficiency</h2>
          <p>
            Usually due to pituitary dysfunction or chronic exogenous steroid suppression.
            Aldosterone is typically preserved.
          </p>
          <div class="callout">Treatment generally requires glucocorticoid replacement without mineralocorticoid replacement.</div>
        </section>

        <section class="section" id="primary-hyperaldosteronism">
          <h2>6. Primary Hyperaldosteronism (Conn Syndrome)</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Clinical Pattern</h3>
              <ul>
                <li>Hypertension</li>
                <li>Hypokalemia</li>
                <li>Metabolic alkalosis</li>
              </ul>
            </div>
            <div class="box">
              <h3>Treatment Branches</h3>
              <ul>
                <li>Bilateral disease: medical therapy (spironolactone)</li>
                <li>Unilateral adenoma: surgical adrenalectomy</li>
              </ul>
            </div>
          </div>

          <div class="box stack">
            <h3>Spironolactone</h3>
            <ul>
              <li>MOA: mineralocorticoid receptor blockade reduces sodium retention and preserves potassium</li>
              <li>Side effects: hyperkalemia, gynecomastia</li>
              <li>Contraindications/caution: significant hyperkalemia or severe renal dysfunction</li>
            </ul>
          </div>
        </section>

        <section class="section" id="management-recap-drill">
          <h2>Management Recap Drill</h2>
          <div class="flow">
            <div class="step"><strong>Cushing:</strong> surgery when possible, medical cortisol control when needed.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Addison:</strong> hydrocortisone plus fludrocortisone replacement.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Adrenal crisis:</strong> immediate IV hydrocortisone and fluids.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Hyperaldosteronism:</strong> spironolactone for bilateral disease or surgery for unilateral adenoma.</div>
          </div>

          <div class="diagram-card">
            <p class="diagram-title">Visual Algorithm Placeholder</p>
            <p>
              [Insert Adrenal Disorder Diagnostic and Treatment Flowchart Here During UI Integration]
            </p>
          </div>
        </section>

        <section class="section refs">
          <h2>Guideline References (Management)</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Endocrine Society Clinical Practice Guidelines</h3>
              <a href="https://www.endocrine.org" target="_blank" rel="noopener">
                https://www.endocrine.org
              </a>
            </div>
            <div class="box">
              <h3>Guideline Scope</h3>
              <ul>
                <li>Cushing syndrome management</li>
                <li>Adrenal insufficiency replacement</li>
                <li>Hyperaldosteronism therapy options</li>
              </ul>
            </div>
          </div>
        </section>

        <section class="section" id="exam-traps">
          <h2>7. Common Exam Traps</h2>
          <div class="stack">
            <div class="callout alert">Exogenous steroid exposure is the most common overall cause of Cushing syndrome.</div>
            <div class="callout alert">Primary adrenal insufficiency often shows hyperpigmentation with hyperkalemia.</div>
            <div class="callout alert">Adrenal crisis treatment must start immediately.</div>
            <div class="callout alert">Secondary adrenal insufficiency usually does not need mineralocorticoid replacement.</div>
            <div class="callout alert">Spironolactone is first-line medical therapy for bilateral primary hyperaldosteronism.</div>
          </div>
        </section>

        <section class="section" id="quick-revision">
          <h2>8. Quick Revision Summary</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Must Remember</h3>
              <ul>
                <li>Cushing equals cortisol excess</li>
                <li>Addison equals cortisol deficiency with mineralocorticoid loss in primary disease</li>
                <li>Adrenal crisis requires urgent steroid and fluid therapy</li>
                <li>Aldosterone excess drives hypertension and hypokalemia</li>
                <li>Gradual steroid taper helps prevent HPA-axis suppression complications</li>
              </ul>
            </div>
            <div class="box">
              <h3>Practice Questions Placeholder</h3>
              <ul>
                <li>Topic: Adrenal Disorders</li>
                <li>
                  Subtopics: Cushing syndrome, Addison disease, adrenal crisis,
                  hyperaldosteronism, steroid tapering
                </li>
              </ul>
            </div>
          </div>
        </section>
      </article>
    </div>
  </body>
</html>
